Myriad Genetics | MYGN - Spese Operative





Spese Operative Cambiamento Data
Agilent USD 1.43B 2M 2026-06
Becton, Dickinson and Co. USD 4.16B 20.25B 2026-09
Bio-Rad Laboratories USD 7.6B 429.1M 2026-09
Bruker USD 790.5M 21.6M 2026-09
Danaher USD 53.62B 1.04B 2026-09
Illumina USD 525M 374M 2026-09
J&J USD 18.93B 1.09B 2026-09
Mettler Toledo International USD 77.66M 662.11M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.62B 34M 2026-09
Quidel USD 606.8M 39.4M 2026-09
Repligen USD 185.01M 2.01M 2026-09
Revvity USD 604.27M 719K 2026-09
Standard Biotools USD 27.93M 2.63M 2026-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Veracyte USD 133.73M 7.37M 2026-09
Waters USD 527M 592M 2026-06